Warning! GuruFocus detected
3 Medium warning signs
with CGN.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
The Cigna Group
NAICS : 524114
SIC : 6324
ISIN : US1255231003
Compare
Compare
Traded in other countries / regions
CI.USA0A77.UKCGN.GermanyCI.MexicoCIGN.AustriaC1IC34.BrazilCI.Peru IPO Date
1982-04-01Description
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 0.78 | |||||
| Debt-to-EBITDA | 3.37 | |||||
| Interest Coverage | 4.67 | |||||
| Piotroski F-Score | 6/9 | |||||
| Beneish M-Score | -7.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 19.1 | |||||
| 3-Year EBITDA Growth Rate | 1.5 | |||||
| 3-Year EPS without NRI Growth Rate | 10.1 | |||||
| 3-Year FCF Growth Rate | 21.3 | |||||
| 3-Year Book Growth Rate | 0.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 10.6 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.06 | |||||
| 9-Day RSI | 67.94 | |||||
| 14-Day RSI | 63.34 | |||||
| 3-1 Month Momentum % | 9.44 | |||||
| 6-1 Month Momentum % | -6.33 | |||||
| 12-1 Month Momentum % | -13.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.72 | |||||
| Dividend Payout Ratio | 0.2 | |||||
| 3-Year Dividend Growth Rate | 11.9 | |||||
| Forward Dividend Yield % | 1.81 | |||||
| 5-Year Yield-on-Cost % | 469.05 | |||||
| 3-Year Average Share Buyback Ratio | 5.4 | |||||
| Shareholder Yield % | 8.62 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 1.41 | |||||
| FCF Margin % | 3.72 | |||||
| ROE % | 8.1 | |||||
| ROA % | 2.22 | |||||
| ROIC % | 4.5 | |||||
| 3-Year ROIIC % | 9.96 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.12 | |||||
| Forward PE Ratio | 10.79 | |||||
| PE Ratio without NRI | 12.14 | |||||
| Shiller PE Ratio | 20.67 | |||||
| Price-to-Owner-Earnings | 15.06 | |||||
| PS Ratio | 0.38 | |||||
| PB Ratio | 2.21 | |||||
| Price-to-Free-Cash-Flow | 10.45 | |||||
| Price-to-Operating-Cash-Flow | 9.03 | |||||
| EV-to-EBIT | 17.1 | |||||
| EV-to-Forward-EBIT | 12 | |||||
| EV-to-EBITDA | 12.09 | |||||
| EV-to-Forward-EBITDA | 10.17 | |||||
| EV-to-Revenue | 0.47 | |||||
| EV-to-Forward-Revenue | 0.45 | |||||
| EV-to-FCF | 12.8 | |||||
| Price-to-GF-Value | 0.78 | |||||
| Price-to-Projected-FCF | 0.61 | |||||
| Price-to-Median-PS-Value | 0.68 | |||||
| Earnings Yield (Greenblatt) % | 5.85 | |||||
| FCF Yield % | 9.95 | |||||
| Forward Rate of Return (Yacktman) % | 6.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
The Cigna Group Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 226,484.963 | ||
| EPS (TTM) (€) | 11.44 | ||
| Beta | 0.09 | ||
| 3-Year Sharpe Ratio | 0.51 | ||
| 3-Year Sortino Ratio | 0.73 | ||
| Volatility % | 23.5 | ||
| 14-Day RSI | 63.34 | ||
| 14-Day ATR (€) | 4.144404 | ||
| 20-Day SMA (€) | 294.055 | ||
| 12-1 Month Momentum % | -13.35 | ||
| 52-Week Range (€) | 251.25 - 340 | ||
| Shares Outstanding (Mil) | 271.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
The Cigna Group Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
The Cigna Group Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
The Cigna Group Frequently Asked Questions
What is The Cigna Group(STU:CGN)'s stock price today?
The current price of STU:CGN is €305.60. The 52 week high of STU:CGN is €340.00 and 52 week low is €251.25.
When is next earnings date of The Cigna Group(STU:CGN)?
The next earnings date of The Cigna Group(STU:CGN) is 2025-05-02 Est..
Does The Cigna Group(STU:CGN) pay dividends? If so, how much?
The Dividend Yield %  of The Cigna Group(STU:CGN) is 1.72% (As of Today), Highest Dividend Payout Ratio of The Cigna Group(STU:CGN) was 0.21. The lowest was 0. And the median was 0.01. The  Forward Dividend Yield % of The Cigna Group(STU:CGN) is 1.81%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers